Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study
Jazyk angličtina Země Spojené arabské emiráty Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
28554308
DOI
10.2174/1570161115666170530104143
PII: CVP-EPUB-83758
Knihovny.cz E-zdroje
- Klíčová slova
- ESRD, HD., dyslipidemia, hemodiafiltration, lipoproteins, survival,
- MeSH
- apolipoprotein B-100 krev MeSH
- biologické markery krev MeSH
- časové faktory MeSH
- cholesterol krev MeSH
- chronické selhání ledvin krev diagnóza MeSH
- dyslipidemie krev diagnóza MeSH
- LDL-cholesterol krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- lipoproteiny krev MeSH
- metabolismus lipidů * MeSH
- následné studie MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- senioři MeSH
- triglyceridy krev MeSH
- VLDL-cholesterol krev MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- APOB protein, human MeSH Prohlížeč
- apolipoprotein B-100 MeSH
- biologické markery MeSH
- cholesterol MeSH
- LDL-cholesterol MeSH
- lipoprotein cholesterol MeSH Prohlížeč
- lipoproteiny MeSH
- triglyceridy MeSH
- VLDL-cholesterol MeSH
BACKGROUND: Patients with end-stage renal disease (ESRD) exhibit high morbidity as well as mortality for atherosclerotic cardiovascular diseases (CVD). Therefore, we investigated differences in individual lipoprotein classes and subclasses in ESRD patients under chronic high volume hemodiafiltration (HV-HDF) in comparison with a control group. We also assessed the prognosis of these patients and analyzed these parameters after 5 years follow-up. METHODS: 57 patients and 50 controls were enrolled. We analysed high density (HDL) and low density (LDL) lipoprotein subfractions using the Quantimetrix Lipoprint(R) system. Subfractions were correlated with selected clinical-biochemical parameters including risk factors for atherosclerotic CVD at the beginning of and after 5 years follow-up. RESULTS: Fourteen patients survived the 5-year follow-up. Follow-up results revealed a shift toward smaller HDL subfractions. In lipoproteins carrying apolipoprotein B, there was a shift of cholesterol from very low density (VLDL) to intermediate density (IDL) lipoproteins and LDLs. Hypolipidaemic therapy did not influence lipoprotein profiles in HV-HDF patients. CONCLUSION: 1. HV-HDF patients exhibit specific lipid profiles with elevated triacylglycerol, low HDL and LDL and higher content of cholesterol in remnant particles (VLDL and IDL) at the expense of large LDL. HDL subfractions were linked to the number of risk factors for CVD in the control group only. 2. Baseline lipoprotein profiles did not differ between survivors and non-survivors. Non-survivors had higher CRP and lower HDL-C. 3. During the 5 year follow-up period, cholesterol in HDL particles and lipoproteins carrying apolipoprotein B redistributed in survivors towards smaller particles, thus resembling the profile of control patients.
Citace poskytuje Crossref.org
